Authorities

Application number, filing date, and completion of application

Claiming benefit of earlier filing date and cross-references to other applications

Claim for foreign priority

Patent application and reexamination processing fees

Inventor’s oath or declaration

Application data sheet

National application filing, search, and examination fees

Affidavit or declaration of prior invention or to disqualify commonly owned patent or published application as prior art

Extensions of time

Affidavit or declaration of attribution or prior public disclosure under the Leahy-Smith America Invents Act

Incorporation by reference

Filing of information disclosure statement

Establishing right of assignee to take action

Filing of correspondence by Priority Mail Express ®

Request for continued examination

Application for patent by an assignee, obligated assignee, or a person who otherwise shows sufficient proprietary interest in the matter

Manner of making amendments in applications

Language, paper, writing, margins, read-only optical disc specifications

Protests by the public against pending applications

Persons eligible to file, and time for filing, a request for inter partes reexamination

Correction of inventorship pursuant to 35 U.S.C. 116 or correction of the name or order of names in a patent application, other than a reissue application

Nature of correspondence and signature requirements

Duty to disclose information material to patentability

Revival of abandoned application, or terminated or limited reexamination prosecution

Micro entity status

Correspondence respecting patent applications, reexamination proceedings, and other proceedings

Certificate of mailing or transmission

Decisions and other actions by the Board

Content of information disclosure statement

Affidavits or declarations traversing rejections or objections

Reply by applicant or patent owner to a non-final Office action

Substitute statement in lieu of an oath or declaration

Inventor’s oath or declaration for a reissue application

Receipt of correspondence

Statutory disclaimers, including terminal disclaimers

Signature and certificate for correspondence filed in the Office

Definition of small entities and establishing status as a small entity to permit payment of small entity fees; when a determination of entitlement to small entity status and notification of loss of entitlement to small entity status are required; fraud on the Office

[Reserved]

Requirements for information

Amendments and affidavits or other evidence after final action and prior to appeal

Nucleotide and/or amino acid sequence disclosures in patent applications

Appeal brief

Amendments after allowance

Questions not specifically provided for

Detailed description and specification of the invention

Standards for drawings

Entering the national stage in the United States of America

Withdrawal from issue

Reissue specification, drawings, and amendments

Transitional procedures for limited examination after final rejection and restriction practice

Abandonment for failure to reply within time period

Suspension of action by the Office

Nature of examination

Patent applications preserved in confidence

General requisites of an application

Power of attorney

Acting in a representative capacity

Inventorship

Chemical and mathematical formulas and tables

Express abandonment

Advancement of examination

Prosecution by assignee

Certificate of correction of applicant’s mistake

Applicant for patent

Files open to the public

Petition to the Director

Submission of computer program listings

National stage fees

Fees

Suspension of rules

Time for appeal or civil action

Amendments and affidavits or other Evidence after appeal

Supplemental oath or declaration

Arrangement of application elements

Substitute specification

Unlocatable file

Refunds when small entity status is later established; how errors in small entity status are excused

Claim(s)

Preliminary amendments

Correction of inventorship in patent, pursuant to 35 U.S.C. 256

Application for patent by a legal representative of a deceased or legally incapacitated inventor

Reissue applicant

Appeal to Board

Jurisdiction over appeal

Examiner’s answer

Document supply fees

Application for patent by joint inventors

Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures

Inventor’s oath or declaration under 35 U.S.C. 371(c)(4)

Expungement of information or copy of papers in application file

Post-issuance fees

Submissions by third parties in applications

Documents which will be recorded

Miscellaneous fees and charges

Times for taking action; Expiration on Saturday, Sunday or Federal holiday

Amendments to add or replace a “Sequence Listing” and CRF copy thereof

Final rejection or action

Information material to patentability in ex parte reexamination and inter partes reexamination proceedings

Amendment to add or replace a “Sequence Listing XML” in patent applications filed on or after July 1, 2022

Refunds